Nirmatrelvir/Ritonavir Utilization for the Treatment of Non-hospitalized Adults with COVID-19 in the National Veterans Affairs (VA) Healthcare System

Nirmatrelvir/Ritonavir Utilization for the Treatment of Non-hospitalized Adults with COVID-19 in the National Veterans Affairs (VA) Healthcare System

Abstract Introduction Limited data exist regarding real-world utilization of nirmatrelvir/ritonavir. We identified predictors of nirmatrelvir/ritonavir use among Veterans Affairs (VA) outpatients nationally. Methods We conducted a retrospective cohort study among outpatients with coronavirus disease...

Celý popis

Podrobná bibliografie
Hlavní autoři: Haley J. Appaneal, Kerry L. LaPlante, Vrishali V. Lopes, Catherine Martin, Laura Puzniak, Timothy L. Wiemken, Evan J. Zasowski, John M. McLaughlin, Aisling R. Caffrey
Médium: Článek
Jazyk:English
Vydáno: Adis, Springer Healthcare 2024-01-01
Edice:Infectious Diseases and Therapy
Témata:
COVID-19
Nirmatrelvir/ritonavir
Predictors
Real-world utilization
Vaccination
On-line přístup:https://doi.org/10.1007/s40121-023-00910-1

Internet

https://doi.org/10.1007/s40121-023-00910-1

Podobné jednotky